Prolonged survival and low incidence of late toxic sequelae in advanced follicular lymphoma treated with a TBI-free autografting program: updated results of the multicenter consecutive GITMO trial. |
| |
| Authors: | M Ladetto S Vallet F Benedetti U Vitolo M Martelli V Callea C Patti P Coser A Perrotti M Sorio C Boccomini A Pulsoni C Stelitano R Scimè M Boccadoro R Rosato F De Marco M Zanni P Corradini C Tarella |
| |
| Affiliation: | Divisione Universitaria di Ematologia, Cattedra di Ematologia, Torino, Italy. marco.ladetto@unito.it |
| |
| Abstract: | This study provides an updated report of the consecutive multicenter Gruppo Italiano Trapianto Midollo Osseo trial employing an intensified, purging-free, total body irradiation-free, high-dose sequential chemotherapy schedule with peripheral blood stem cell autograft (i-HDS) in advanced-stage follicular lymphoma (FL). Special interest has been devoted to late toxicities and outcome in terms of molecular status. Ninety-two untreated FL patients aged
|
| |
| Keywords: | |
|
|
